Unlocking the Future of the Neuroendocrine Tumor Treatment Market: Growth Rate, Key Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the neuroendocrine tumor treatment market size evolved in recent years?
The market for neuroendocrine tumor treatment has expanded swiftly in the past few years. The market value is predicted to rise from $2.17 billion in 2024 to $2.4 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.6%. The exponential growth over the historical span can be credited to factors such as the advances in clinical knowledge and research, increased awareness and education, expert medical assistance, progression in radiation therapy, and enhanced support care services.
What are the predictions for the neuroendocrine tumor treatment market size in the coming years?
The neuroendocrine tumor treatment market is projected to experience substantial growth in the coming years. It is anticipated to reach $3.6 billion by 2029, with a compound annual growth rate (CAGR) of 10.7%. This growth in the forecast period can be credited to advancements in precision medicine, innovative immunotherapies, minimally invasive practices, increasing occurrence rates, along with the rise of telemedicine and remote care. Key trends expected to shape the forecast period comprise progress in diagnostic technologies, advancements in peptide receptor radionuclide therapy (PRRT), breakthroughs in nanotechnology drug delivery, the emergence of new radiopharmaceuticals, and interdisciplinary cooperation.
Get your neuroendocrine tumor treatment market report here!
What key factors are fueling the growth of the neuroendocrine tumor treatment market?
The increasing occurrence of neuroendocrine tumors will likely drive the expansion of the neuroendocrine tumor treatment market in the future. Neuroendocrine tumors, also known as NETs, are a unique type of tumor that begins in neuroendocrine cells. Effective treatment tackling neuroendocrine tumors is crucial, enabling symptom management, tumor growth restriction, and the employment of radiation therapy to exterminate tumor cells. For illustration, as indicated in March 2023 reports made available by the American Society of Clinical Oncology (ASCO), a US professional body, over 12,000 people annually receive a neuroendocrine tumor diagnosis in the US, with an estimated 171,000 individuals living with this prognosis in 2023. Moreover, data provided by Cancer Australia, an Australian cancer control institution, in August 2022 states that 5,437 Australians were identified with neuroendocrine tumors in 2022, accounting for 3.4% of all diagnoses that year. Consequently, the rising incidence of neuroendocrine tumors is propelling the progression of the neuroendocrine tumor treatment market.
How is the global neuroendocrine tumor treatment market divided into key segments?
The neuroendocrine tumor treatment market covered in this report is segmented –
1) By Product: Somatostatin Analogs (SSAs), Targeted Therapy, Chemotherapy, Others Products
2) By Indication: Lungs, Pancreas, Gastrointestinal, Others Indications
3) By End-Users: Hospitals, Oncology Centers, Other End-Users
Subsegments:
1) By Somatostatin Analogs (SSAs): Octreotide, Lanreotide
2) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs), Peptide Receptor Radionuclide Therapy (PRRT)
3) By Chemotherapy: Traditional Chemotherapy Agents, Combination Chemotherapy Regimens
4) By Other Products: Immunotherapy, Supportive Care Medications
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12248&type=smp
Who are the key firms paving the way for growth in the neuroendocrine tumor treatment market?
Major companies operating in the neuroendocrine tumor treatment market include Pfizer Inc., F Hoffmann-La Roche AG, Abbvie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca, Takeda Pharmaceutical, Eli Lilly And Company, Amgen Inc., Merck & Co. Inc., Boehringer Ingelheim International GmbH, Servier, Teva Pharmaceutical Industries Ltd., Ipsen Pharma SAS, Exelixis Inc., Advanced Accelerator Applications SA, Hutchison Medipharma Ltd., Tarveda Therapeutics, GlycoMira Therapeutics Inc, AVEO Pharmaceuticals Inc., Progenics Pharmaceuticals Inc., Callisto Pharmaceuticals Pvt Ltd., Chiasma Inc.
Which trends are expected to transform the neuroendocrine tumor treatment market?
A rising trend in the neuroendocrine tumor treatment market is the clinical development of drugs for treatment. In order to maintain their market standing, key companies are creating innovative therapies. For example, Viewpoint Molecular Targeting, Inc., a pharmaceutical company based in the US, announced in October 2022 that the U.S. Food and Drug Administration (FDA), a federal agency also based in the US, has granted a fast-track designation for the development of [212Pb] VMT-α-NET, aimed at treating patients with SSTR2-positive unresectable or metastatic neuroendocrine tumors (NETs). VMT-α-NET is a targeted alpha-particle therapy (TAT), designed to eliminate cancer cells that selectively express somatostatin receptors. The fast-track designation by the FDA aims for the quickened development and evaluation of [212Pb] VMT-α-NET for NETs treatment. Such a designation is given to drugs which potentially offer a considerable improvement on the safety or effectiveness of treatment for severe conditions.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12248
What regions are contributing significantly to the growth of the neuroendocrine tumor treatment market?
North America was the largest region in the neuroendocrine tumor treatment market in 2024. The regions covered in the neuroendocrine tumor treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Filling Machines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/filling-machines-global-market-report
Food Automation Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/food-automation-global-market-report
Grain Processing Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/grain-processing-equipment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
